- Home
- KURA vs DNUT Comparison
KURA vs DNUT Comparison
Compare KURA & DNUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KURA
- DNUT
- Stock Information
- Founded
- KURA 2014
- DNUT 1937
- Country
- KURA United States
- DNUT United States
- Employees
- KURA N/A
- DNUT N/A
- Industry
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- DNUT Food Chains
- Sector
- KURA Health Care
- DNUT Consumer Staples
- Exchange
- KURA Nasdaq
- DNUT Nasdaq
- Market Cap
- KURA 713.5M
- DNUT 578.7M
- IPO Year
- KURA N/A
- DNUT 2021
- Fundamental
- Price
- KURA $10.14
- DNUT $3.37
- Analyst Decision
- KURA Buy
- DNUT Buy
- Analyst Count
- KURA 14
- DNUT 6
- Target Price
- KURA $24.45
- DNUT $6.22
- AVG Volume (30 Days)
- KURA 1.8M
- DNUT 5.2M
- Earning Date
- KURA 11-06-2025
- DNUT 11-06-2025
- Dividend Yield
- KURA N/A
- DNUT 3.06%
- EPS Growth
- KURA N/A
- DNUT N/A
- EPS
- KURA N/A
- DNUT N/A
- Revenue
- KURA $83,279,000.00
- DNUT $1,538,841,000.00
- Revenue This Year
- KURA $68.63
- DNUT N/A
- Revenue Next Year
- KURA $141.59
- DNUT $0.71
- P/E Ratio
- KURA N/A
- DNUT N/A
- Revenue Growth
- KURA N/A
- DNUT N/A
- 52 Week Low
- KURA $5.41
- DNUT $2.50
- 52 Week High
- KURA $19.73
- DNUT $12.68
- Technical
- Relative Strength Index (RSI)
- KURA 69.23
- DNUT 47.69
- Support Level
- KURA $9.48
- DNUT $3.41
- Resistance Level
- KURA $9.96
- DNUT $3.95
- Average True Range (ATR)
- KURA 0.41
- DNUT 0.23
- MACD
- KURA 0.06
- DNUT 0.00
- Stochastic Oscillator
- KURA 81.78
- DNUT 36.22
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
About DNUT Krispy Kreme Inc.
Krispy Kreme Inc is a sweet treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations across the globe. It derives maximum revenue from the U.S. segment.